{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:54:09Z","timestamp":1777870449307,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study explores vascular access complications in patients established on in-centre nocturnal haemodialysis (INHD) compared to conventional haemodialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective cohort study; patients acted as their own control. Data were collected from three centres. Adults established on INHD (intervention) preceded by usual daytime haemodialysis (control) were eligible. Data were collected between 01\/01\/2009 and 12\/31\/2021. The data collection period was up to 12\u00a0months for both control and intervention periods.<\/jats:p>\n                    <jats:p>\n                      The primary outcome was a composite of outcomes related to vascular access complications: hospitalisation, intervention, change in vascular access modality, change in dialysis modality and death. The primary outcome was evaluated by time-to-event rate in days using Kaplan\u2013Meier plots. Statistical significance was accepted at a\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05\n                      <jats:italic>.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One hundred forty-five individuals were included: median age was 52.0\u00a0years (IQR 36.0\u201365.0), 71.0% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009103) were male, and 57.2% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200983) were White.\n                    <\/jats:p>\n                    <jats:p>\n                      The primary outcome occurred in 24.1% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200935) during the intervention and in 25.5% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200937) during the control period (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.875). The 12-month vascular access survival probability was 73.4% (95%CI 65.8\u201381.0%) for the intervention and 70.6% (95%CI 62.4%-78.8%) for the control period.\n                    <\/jats:p>\n                    <jats:p>\n                      During the intervention period, arteriovenous grafts were associated with lower vascular access survival (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Regular vitamin K antagonist was associated with a lower 12-month vascular access survival for both the intervention (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.044) and the control periods (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There does not appear to be an increased risk to vascular access events for INHD compared to daytime haemodialysis. Vascular access type and regular anticoagulation were associated with a reduced vascular access survival probability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-025-02431-1","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:13:43Z","timestamp":1758888823000},"page":"2651-2661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring vascular access survival in prevalent thrice-weekly in-centre nocturnal haemodialysis patients"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0028-5408","authenticated-orcid":false,"given":"Katherine L.","family":"Hull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Bugeja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P. M.","family":"Graham-Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiden J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigit C.","family":"van Jaarsveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James O.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"6","key":"2431_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/MNH.0000000000000450","volume":"27","author":"JO Burton","year":"2018","unstructured":"Burton JO, Graham-Brown MP (2018) Nocturnal hemodialysis: an underutilized modality? Curr Opin Nephrol Hypertens 27(6):472\u2013477","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2431_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-019-1527-3","volume":"20","author":"D Ashby","year":"2019","unstructured":"Ashby D, Borman N, Burton J, Corbett R, Davenport A, Farrington K et al (2019) Renal association clinical practice guideline on haemodialysis. BMC Nephrol 20:1\u201336","journal-title":"BMC Nephrol"},{"issue":"10","key":"2431_CR3","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/ki.2011.213","volume":"80","author":"MV Rocco","year":"2011","unstructured":"Rocco MV, Lockridge RS, Beck GJ, Eggers PW, Gassman JJ, Greene T et al (2011) The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial. Kidney Int 80(10):1080\u20131091","journal-title":"Kidney Int"},{"issue":"2","key":"2431_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/hdi.12828","volume":"24","author":"KL Hull","year":"2020","unstructured":"Hull KL, March DS, Churchward DR, Graham-Brown MP, Burton JO (2020) The effect of extended-hours hemodialysis on outcomes: a systematic review and meta-analysis. Hemodial Int 24(2):133\u2013147","journal-title":"Hemodial Int"},{"issue":"3","key":"2431_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000362106","volume":"37","author":"T Cornelis","year":"2014","unstructured":"Cornelis T, Usvyat LA, Tordoir JH, Wang Y, Wong M, Leunissen KM et al (2014) Vascular access vulnerability in intensive hemodialysis: a significant Achilles\u2019 heel? Blood Purif 37(3):222\u2013228","journal-title":"Blood Purif"},{"issue":"2","key":"2431_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/j.ajkd.2012.08.032","volume":"61","author":"M Jun","year":"2013","unstructured":"Jun M, Jardine MJ, Gray N, Masterson R, Kerr PG, Agar JW et al (2013) Outcomes of extended-hours hemodialysis performed predominantly at home. Am J Kidney Dis 61(2):247\u2013253","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2431_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000046957","volume":"19","author":"DO McGregor","year":"2001","unstructured":"McGregor DO, Buttimore AL, Lynn KL, Nicholls MG, Jardine DL (2001) A comparative study of blood pressure control with short in-center versus long home hemodialysis. Blood Purif 19(3):293\u2013300","journal-title":"Blood Purif"},{"key":"2431_CR8","doi-asserted-by":"crossref","unstructured":"Palmer SC, Palmer AR, Craig JC, Johnson DW, Stroumza P, Frantzen L, et al. Home versus in\u2010centre haemodialysis for end\u2010stage kidney disease. Cochrane Database Syst Rev, 2014(11)","DOI":"10.1002\/14651858.CD009535.pub2"},{"issue":"10","key":"2431_CR9","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1681\/ASN.2012121234","volume":"24","author":"P Ravani","year":"2013","unstructured":"Ravani P, Gillespie BW, Quinn RR, MacRae J, Manns B, Mendelssohn D et al (2013) Temporal risk profile for infectious and noninfectious complications of hemodialysis access. J Am Soc Nephrol 24(10):1668\u20131677","journal-title":"J Am Soc Nephrol"},{"issue":"24","key":"2431_CR10","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1056\/NEJMoa1001593","volume":"363","author":"FHN Group","year":"2010","unstructured":"FHN Group (2010) In-center hemodialysis six times per week versus three times per week. N Engl J Med 363(24):2287\u20132300","journal-title":"N Engl J Med"},{"issue":"4","key":"2431_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/ki.2014.96","volume":"86","author":"MT Parisotto","year":"2014","unstructured":"Parisotto MT, Schoder VU, Miriunis C, Grassmann AH, Scatizzi LP, Kaufmann P et al (2014) Cannulation technique influences arteriovenous fistula and graft survival. Kidney Int 86(4):790\u2013797","journal-title":"Kidney Int"},{"issue":"5","key":"2431_CR12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.ajkd.2020.11.024","volume":"77","author":"KI Greenberg","year":"2021","unstructured":"Greenberg KI, Choi MJ (2021) Hemodialysis emergencies: core curriculum 2021. Am J Kidney Dis 77(5):796\u2013809","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2431_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1053\/j.ajkd.2017.05.014","volume":"70","author":"MD Jose","year":"2017","unstructured":"Jose MD, Marshall MR, Read G, Lioufas N, Ling J, Snelling P, Polkinghorne KR (2017) Fatal dialysis vascular access hemorrhage. Am J Kidney Dis 70(4):570\u2013575","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2431_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.37526\/1526-744X.2021.48.4.347","volume":"48","author":"J Speranza-Reid","year":"2021","unstructured":"Speranza-Reid J, Brouwer-Maier D, Cruz CM, Inglese M (2021) Venous needle dislodgement and access-bloodline separation. Nephrol Nurs J 48(4):347","journal-title":"Nephrol Nurs J"},{"issue":"2","key":"2431_CR15","first-page":"113","volume":"42","author":"T Kear","year":"2015","unstructured":"Kear T, Ulrich B (2015) Patient safety and patient safety culture in nephrology nurse practice settings: issues, solutions, and best practices. Nephrol Nurs J 42(2):113","journal-title":"Nephrol Nurs J"},{"issue":"1_suppl","key":"2431_CR16","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.5301\/jva.5000526","volume":"17","author":"A Moufarrej","year":"2016","unstructured":"Moufarrej A, Tordoir J, Mees B (2016) Graft modification strategies to improve patency of prosthetic arteriovenous grafts for hemodialysis. J Vasc Access 17(1_suppl):S85\u2013S90","journal-title":"J Vasc Access"},{"issue":"6","key":"2431_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2022.100456","volume":"4","author":"NS Roetker","year":"2022","unstructured":"Roetker NS, Guo H, Ramey DR, McMullan CJ, Atkins GB, Wetmore JB (2022) Hemodialysis vascular access and risk of major bleeding, thrombosis, and cardiovascular events: a cohort study. Kidney Med 4(6):100456","journal-title":"Kidney Med"},{"issue":"5","key":"2431_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5414\/CN109572","volume":"91","author":"MMY Mok","year":"2019","unstructured":"Mok MMY, Chan CT (2019) Risk factors affecting arteriovenous access patency in nocturnal home hemodialysis patients. Clin Nephrol 91(5):284","journal-title":"Clin Nephrol"},{"key":"2431_CR19","unstructured":"Aitken E, Anijeet H, Ashby D, Barrow W, Calder F, Dowds B, et al. UK kidney association clinical practice guideline. Vascular access for haemodialysis. 2023."},{"issue":"6","key":"2431_CR20","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1053\/ajkd.2002.36895","volume":"40","author":"R Saran","year":"2002","unstructured":"Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW (2002) Association between vascular access failure and the use of specific drugs: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 40(6):1255\u20131263","journal-title":"Am J Kidney Dis"},{"key":"2431_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.avsg.2021.08.032","volume":"80","author":"A Kumpfbeck","year":"2022","unstructured":"Kumpfbeck A, Rockman CB, Jacobowitz GR, Lugo JZ, Barfield ME, Scher LA et al (2022) Anticoagulation therapy is associated with increased access-related wound infections after hemodialysis access creation. Ann Vasc Surg 80:136\u2013142","journal-title":"Ann Vasc Surg"},{"issue":"9","key":"2431_CR22","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1097\/01.ASN.0000027356.16598.99","volume":"13","author":"MA Crowther","year":"2002","unstructured":"Crowther MA, Clase CM, Margetts PJ, Julian J, Lambert K, Sneath D et al (2002) Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol 13(9):2331\u20132337","journal-title":"J Am Soc Nephrol"},{"key":"2431_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-019-1604-7","volume":"20","author":"S Jeong","year":"2019","unstructured":"Jeong S, Kwon H, Chang JW, Kim M-J, Ganbold K, Han Y et al (2019) Effects of patient age on patency of chronic hemodialysis vascular access. BMC Nephrol 20:1\u20138","journal-title":"BMC Nephrol"},{"issue":"6","key":"2431_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1053\/j.ajkd.2017.11.020","volume":"71","author":"KJ Woodside","year":"2018","unstructured":"Woodside KJ, Bell S, Mukhopadhyay P, Repeck KJ, Robinson IT, Eckard AR et al (2018) Arteriovenous fistula maturation in prevalent hemodialysis patients in the United States: a national study. Am J Kidney Dis 71(6):793\u2013801","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2431_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/1129729819845562","volume":"21","author":"J Gameiro","year":"2020","unstructured":"Gameiro J, Ibeas J (2020) Factors affecting arteriovenous fistula dysfunction: a narrative review. J Vasc Access 21(2):134\u2013147","journal-title":"J Vasc Access"},{"key":"2431_CR26","unstructured":"UKRR. UK Renal Registry 26th Annual Report\u2014data to 31\/12\/2022 Bristol, UK2024 [Available from: https:\/\/ukkidney.org\/audit-research\/annual-report."},{"issue":"4","key":"2431_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1681\/ASN.2011070674","volume":"23","author":"E Lacson","year":"2012","unstructured":"Lacson E, Xu JL, Suri RS, Nesrallah G, Lindsay R, Garg AX et al (2012) Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. J Am Soc Nephrol 23(4):687\u2013695","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2431_CR28","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/ndt\/gfq724","volume":"26","author":"E Ok","year":"2011","unstructured":"Ok E, Duman S, Asci G, Tumuklu M, Onen Sertoz O, Kayikcioglu M et al (2011) Comparison of 4-and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: a prospective, case-controlled study. Nephrol Dial Transplant 26(4):1287\u20131296","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2431_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4097\/kja.21165","volume":"74","author":"C-Y Lim","year":"2021","unstructured":"Lim C-Y, In J (2021) Considerations for crossover design in clinical study. Korean J Anesthesiol 74(4):293\u2013299","journal-title":"Korean J Anesthesiol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02431-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02431-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02431-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:49Z","timestamp":1777564789000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/9\/2651\/8462692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2431"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02431-1","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no relevant disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work was reviewed and registered at each of the participating sites: University Hospitals of Leicester NHS Trust registered project number: 12494; The Ottawa Hospital registered project number: 20230336-01H; and Nephrocare DiaPriva Dialysis Centre registered project number: DP20240516.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Individual informed consent was not required at the collaborating centres for retrospective data collection from clinical records.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}